|85.24|| +0.05 / +0.06%|
Endo International plc is a global specialty healthcare company, which focuses on improving patients' lives while creating value. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices through its operating companies: Endo Pharmaceuticals, Qualitest, AMS, Paladin Labs and SOMAR. Endo Pharmaceuticals is focused on developing and delivering high-value branded products that meet the unmet needs of patients. American Medical Systems (AMS) is a diversified supplier of medical devices and procedures to treat incontinence, sexual dysfunction, benign prostatic hyperplasia (BPH), and other pelvic disorders in men and women. Qualitest provides affordable generic pharmaceuticals. Paladin Labs is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. SOMAR is a leading pharmaceutical company focused on the development, manufacturing, marketing and commercialization of high-quality products across key market segments in Mexico. Endo International was founded on October 31, 2013 and is headquartered Dublin, Ireland.
|Rajiv De Silva||President, Chief Executive Officer & Director|
|Robert J. Cobuzzi||SVP-Operations, Research & Development Strategy|
|Suketu P. Upadhyay||Chief Financial Officer & Executive Vice President|
|Susan T. Hall||Chief Scientific Officer & Executive VP|
|Caroline B. Manogue||Chief Legal Officer & Executive VP|